Growth potential Target mid‑sized surgical facilities and specialty clinics that perform urology, orthopedics, ENT, gynecology, GI, and general surgery, highlighting Trimedyne’s laser and disposable delivery systems as tools to reduce bleeding, shorten recovery times, and lower hospital stays.

Clinical differentiation Position Trimedyne’s proprietary delivery systems and laser technology as a value proposition for reducing intraoperative trauma and post‑operative recovery time, leveraging case‑based ROI to appeal to procurement and surgical leadership.

Expansion opportunities Leverage the small company size and modern tech stack to pursue rapid pilots or limited deployments in hospitals and ambulatory surgery centers, offering scalable kits and service contracts to drive adoption.

Partnership channels Develop partnerships with larger OEMs or distributors in the medical device space to extend reach into larger networks, using co‑branding and white‑label delivery systems to expand market access.

Financial messaging Emphasize attainable revenue growth potential and cost savings in trials, with transparent pricing models and measurable clinical outcomes to attract capital‑efficient buyers and hospital procurement teams.